ShinEtsu Chemical Co. (SHECY)
(Delayed Data from OTC)
$20.00 USD
+0.82 (4.28%)
Updated Aug 6, 2024 03:59 PM ET
5-Strong Sell of 5 5
F Value C Growth D Momentum F VGM
Price, Consensus and EPS Surprise
SHECY 20.00 +0.82(4.28%)
Will SHECY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SHECY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SHECY
Best Momentum Stocks to Buy for March 27th
Here's What Could Help ShinEtsu Chemical Co. (SHECY) Maintain Its Recent Price Strength
SHECY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Shin-Etsu (SHECY) QST Substrates to Power Future GaN Devices
Is Brennt (BNTGY) a Great Value Stock Right Now?
Here is Why Growth Investors Should Buy ShinEtsu Chemical Co. (SHECY) Now
Other News for SHECY
Fidelity International Discovery Fund Q2 2024 Review
SHECY Stock Earnings: Shin-Etsu Chemical Reported Results for Q1 2025
IN BRIEF: Shin-Etsu puts in better than forecast quarterly performance
Stock market today: Asian shares falter after Nvidia rebound supports Wall St
Shin-Etsu Chemical Remains A Superior Operator And Well-Leveraged To End-Market Recoveries